SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-001870
Filing Date
2024-01-05
Accepted
2024-01-05 17:00:12
Documents
15
Period of Report
2024-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm241594d1_8k.htm   iXBRL 8-K 31994
2 EXHIBIT 10.1 tm241594d1_ex10-1.htm EX-10.1 11638
6 GRAPHIC tm241594d1_ex10-1img001.jpg GRAPHIC 8988
7 GRAPHIC tm241594d1_ex10-1img002.jpg GRAPHIC 19432
  Complete submission text file 0001104659-24-001870.txt   261665

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20240102.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20240102_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20240102_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT tm241594d1_8k_htm.xml XML 3312
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 24517113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)